Robert Weissert
Robert Weissert, MD, Ph.D., did his training in neurology, neuroimmunology, immunology, and genetics in Tuebingen, Germany; Miami and Chicago, USA; and the Karolinska Institute, Sweden. Between 1999 and 2007, in addition to his clinical duties as a neurologist at the University Hospital in Tuebingen, he headed a group of experimental neuroimmunology funded by the German Research Foundation (DFG) at the Hertie Institute of Clinical Brain Research. From 2007 to 2010, he worked as a director of research and development of a large pharmaceutical company in Geneva, Switzerland, and was a senior physician in the Department of Neurology, Cantonal Hospital, University of Geneva. Since 2011, Dr. Weissert has been working as a senior physician (neurology) and researcher at the University of Regensburg, Germany, where he had been a university professor of clinical neurobiology with a focus on neuroimmunology and neuroinflammation from 2012 to 2018. Since 2018, he has been an honorary professor at the University of Regensburg. Dr. Weissert has made important contributions to the understanding of the pathogenesis of neuroimmunological diseases and the establishment of novel treatment options with a focus on multiple sclerosis.